Next Article in Journal
Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic
Previous Article in Journal
Metaproteomics Reveals Alteration of the Gut Microbiome in Weaned Piglets Due to the Ingestion of the Mycotoxins Deoxynivalenol and Zearalenone
 
 
Article
Peer-Review Record

Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1

by Maren Schenke 1, Hélène-Christine Prause 1,2, Wiebke Bergforth 1, Adina Przykopanski 3, Andreas Rummel 3, Frank Klawonn 4,5 and Bettina Seeger 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Submission received: 31 July 2021 / Revised: 10 August 2021 / Accepted: 19 August 2021 / Published: 22 August 2021
(This article belongs to the Section Bacterial Toxins)

Round 1

Reviewer 1 Report

In the paper, the authors aimed to generate human MNs from induced pluripotent stem 
cells (iPSCs) with different protocols and to evaluate the sensitivity to BoNT/A1 and B1
in order to compare it to the SiMa. The authors were able to show human MNs' ability to detect lower activities of BoNT/A1 than the mouse bioassay and SiMa cells. 
In addition, the authors showed that human MNs could be used to quantify the potency of BoNT/B1, which SiMa cells were not capable of.

The paper is well-written, it is well-supported by the literature and methods/results are presented with sufficient information. I suggest accepting the paper after minor suggestion.

Minor suggestion:

1) Table A1 - under Dilution column 1.1000 should be 1:1000? 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The aim is the determination of the sensitivity of iPSC-differentiated human motor neurons to 2 BoNT/A1 and B1, and found that the human motor neuron is superior to the established neuroblastoma 3 cell line SiMa. The authors describe the technique with precision. The methodology is appropriate. This article gives very interesting elements of understanding the direct iPSC differentiated human motor neurons could be standardized tool for avoiding animal bioassays. Partial improvement of the text would help readers of “Toxins” understanding the article.

Title should be amended that it reveals the conclusion of the study, and the title does not cover all of your studies in one sentence. I would recommend revising it from “Sensitivity of iPSC-differentiated human motor neurons to 2 BoNT/A1 and B1 is superior to the established neuroblastoma 3 cell line SiMa” to “Sensitivity of iPSC-differentiated human motor neurons in 2 BoNT/A1 and B1”.

Abstract: Please have “iPSC” in the abstract not to be abbreviated form. It would be better to have cosmetics deleted in the abstract section. Cosmetics are one of the medical treatments that is unnecessary in the abstract.

Introduction: I would shorten introduction by focusing more on serotypes A and B, which is in clinical use of. I would specify serotype A and B. “For now, two BoNT serotypes (A and B) are routinely used, but more are undergoing clinical studies [7,8].” Is the following paragraph necessary? “So far, seven major serotypes, A-G, with a multitude of 43 subtypes, have been described. Among them, A, B, E and F can cause Botulism in humans 44 with lethal oral doses as low as 1 µg/kg body weight [9]..”

Result: It is well written with detailed, understandable data presentation with the figures, which are adequate.

Discussion and method: It is a well designed study investigating the use of iPSC-differentiated human motor neurons. However, the discussion are too long with unnecessary background information that are out of points. I would recommend shortening the discussion and having a paragraph of conclusion at the last of the discussion.

Author Response

Please see attachment.

Author Response File: Author Response.docx

Back to TopTop